4-{[(1R)-2-{[(2R)-2-...
Check on isomerdesign
PD-134308
Check on drugmap
PD-134308
Check on drugmap
PD-134308
Check on drugmap
PD-134308
Check on drugmap
CI-988
Check on wiki
Data
InChI: InChI=1S/C35H42N4O6/c1-35(18-26-19-36-28-10-6-5-9-27(26)28,39-34(44)45-32-24-14-21-13-22(16-24)17-25(32)15-21)33(43)37-20-29(23-7-3-2-4-8-23)38-30(40)11-12-31(41)42/h2-10,19,21-22,24-25,29,32,36H,11-18,20H2,1H3,(H,37,43)(H,38,40)(H,39,44)(H,41,42)
Synonyms: PD-136621, 4-[[(1R)-2-[[(2R)-3-(1H-Indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.13,7]dec-2-yloxy)carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-4-oxobutanoic Acid,CHEMBL2062144, 4-[(S)-2-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoylamino]-1-phenylethylamino]-4-oxobutyric acid,PD-137342, CHEMBL2062154,4-({(1R)-2-[(N-{[(Adamantan-2-yl)oxy]carbonyl}-α-methyl-D-tryptophyl)amino]-1-phenylethyl}amino)-4-oxobutanoic acid,CHEMBL263969, CHEMBL287735,PD-137337, BDBM50281735, PD-137342, CHEMBL169615,CI-988, CHEMBL2304062, CAM-1241, PD-134308, BDBM50422043, BDBM50449747, 4-[(R)-2-[(S)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoylamino]-1-phenylethylamino]-4-oxobutyric acid, PD 134308, UNII-2637PDX9SI, 2637PDX9SI,4-{[(1R)-2-{[(2R)-2-({[(Adamantan-2-yl)oxy]carbonyl}amino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino}-1-phenylethyl]amino}-4-oxobutanoic acid, PD-136621, 130332-27-3, N-{(S)-2-[(S)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionylamino]-1-phenyl-ethyl}-succinamic acid, CI 988, 4-(((R)-2-((R)-2-(((Adamantan-2-yloxy)carbonyl)amino)-3-(1H-indol-3-yl)-2-methylpropanamido)-1-phenylethyl)amino)-4-oxobutanoic acid
Estimated data
Solubility: -5.984 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: No (prediction using frontiersin.org)
Addictivity Prediction: 37.9% (prediction based on www.mdpi.com)
